Srdan Verstovsek, MD, PhD, of the University of Texas MD Anderson Cancer Center, Houston, TX, discusses key developments in the treatment of myeloproliferative neoplasms (MPNs) presented at the 25th Annual European Hematology Association (EHA) conference. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).